Uncategorized

2104-38233

Developing new methods and devices for later abortion

  Consultants in Obstetric and Gynecologic Ultrasonography and Surgery, PLLC
Ethiopia, United States, and Mexico

The Dupont Clinic innovation evaluates three devices in different countries to improve the provision of later safe abortion. Three provider sites in Mexico, Ethiopia, and the United States will develop and implement these new methods: Lidocaine for fetal demise, DuPont Cannula, and a novel cervical dilation device. Patient and provider feedback will be provided by the sites, and will cover a range of facility sizes and patient populations. The combination of these technologies will make later abortion safer, simpler, and more feasible in most settings.

Uncategorized

2001-36687

Induced Luteal Regression as a Novel Approach for Pregnancy Termination

  Oregon Health and Science University                      United States

Oregon Health and Science University seeks a novel medical abortifacient by identifying gene targets to block progesterone production during the first trimester. This will be conducted through database and laboratory research exploring existing medications which act on these targets. The ultimate goal of the project is to identify a new low-cost and accessible abortion method option.

Uncategorized

1902-31815

Development of new abortion medications by using existing medications in new ways

  Gynuity            United-States​

Gynuity Health Projects assesses existing medications to identify alternative safe and effective abortifacients. Gynuity will conduct a comprehensive literature review of each medication to assess the potential effectiveness, the possible barriers to development and the likelihood to fill market gaps. In consultation with an advisory group, Gynuity will then conduct a preliminary dosing and safety study with the most promising candidate.